Eliciting immune responses against primary tumours is hampered by their
immunosuppressive microenvironment and by the greater inaccessibility of deeper …

Rapid, efficient, and precise cancer therapy is highly desired. Here, this work reports
solvothermally synthesized photoactivatable Pt (IV)‐coordinated carbon dots (Pt‐CDs) and …

Pro-tumoral macrophages in lung tumors present a significant challenge in immunotherapy.
Here, we introduce a pH-responsive nanomedicine approach for activating anti-tumoral …

Lung cancer is the number one cause of cancer-related deaths. The malignancy is
characterized by dismal prognosis and poor clinical outcome mostly due to advanced-stage …

Lymph node metastasis is a major factor that affects prognosis in patients with lung
adenocarcinoma (LUAD). In some cases, lymph node metastasis has already occurred …

The triggering receptor expressed on myeloid cell 1 (TREM1) plays a critical role in
development of chronic inflammatory disorders and the inflamed tumor microenvironment …

Understanding the role of the tumor microenvironment (TME) in lung cancer is critical to
improving patient outcomes. We identified four histology-independent archetype TMEs in …

Background Disappointing clinical efficacy of standard treatment has been proven in
refractory metastatic osteosarcoma, and the emerging anti-angiogenic regimens are still in …

Recent evidence has indicated that overexpression of the epigenetic reader bromodomain‐
containing protein 4 (BRD4) contributes to a poor prognosis of lung cancers, and the …

Breast cancer is the most common tumor in women, and the metastasis further increases the
malignancy with extremely high mortality. However, there is almost no effective method in …